News Summary
PositiveBruker returned to organic revenue growth in Q2 2026 with strong Scientific Instruments bookings (+10% organic) and significant margin expansion (non-GAAP operating margin 14.1% vs. 9.0% YoY), though results were masked by a $134.9M goodwill impairment charge. FY2026 guidance maintained at $2.10–$2.15 non-GAAP EPS (up 15–17% YoY) despite currency headwinds, with a reorganization expected to deliver an additional $20M in cost savings for FY2027.
Red flags
- •Weak U.S. academic and government order demand ongoing
- •Semiconductor delivery timing shifts from Q3 to Q4 creating Q3 revenue risk
- •Q2 GAAP operating loss of $(65.3)M and GAAP diluted loss per share of $(0.41) driven by large goodwill impairment, indicating prior M&A or segment revaluation concerns
- •Heavy reliance on Q4 backlog to meet full-year targets increases execution risk
- •Currency headwind of approximately $0.10 (~5%) to FY2026 non-GAAP EPS
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Sachem Head Capital | Scott Ferguson | 2.9M | +2.9M | $175M | 3.6% | — | NEW |
| Viking Global | Andreas Halvorsen | 893K | +893K | $54M | 0.2% | — | NEW |
| Glenview Capital | Larry Robbins | 252K | +252K | $15M | 0.3% | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where BRKR ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #13 of this fund's book
- 10GDS Hldgs Ltd$261M
- 11Gildan Activewear Inc$188M
- 12GOLAR LNG LTD$180M
- 13Bruker Corp$175M
- 14STMicroelectronics N V$165M
- 15Bitdeer Technologies Group$153M
- 16Twilio Inc$128M
position #36 of this fund's book
- 33BAKER HUGHES COMPANY$27M
- 34ELEVANCE HEALTH INC FORMERLY$26M
- 35MICROCHIP TECHNOLOGY INC.$24M
- 36BRUKER CORP$15M
- 37NOVARTIS AG$14M
- 38DIGITALOCEAN HLDGS INC$13M
- 39PRIMO BRANDS CORPORATION$10M
Values are quarter-end position sizes. Shown only for funds where BRKR ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Insider Activity
Beneficial Ownership (13D/13G)
| Filer | Form | Shares | % of Class | Filed | Src |
|---|---|---|---|---|---|
| FMR LLC | SC 13G/A | 23.3M | 15.0% | 2026-08-06 | ↗ |
| ORBIS INVESTMENT MANAGEMENT LTD | SC 13G/A | 16.9M | 11.1% | 2026-05-15 | ↗ |
| FMR LLC | SC 13G/A | 19.2M | 12.4% | 2026-05-06 | ↗ |
SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.